Literature DB >> 417628

Pulmonary involvement in Fabry's disease.

K Kariman, W V Singletary, H O Sieker.   

Abstract

Entities:  

Mesh：

Year:  1978        PMID： 417628     DOI： 10.1016/0002-9343(78)90542-9

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  4 in total

1.  Peripheral blood mononuclear cell gene expression in chronic obstructive pulmonary disease.

Authors:  Timothy M Bahr; Grant J Hughes; Michael Armstrong; Rick Reisdorph; Christopher D Coldren; Michael G Edwards; Christina Schnell; Ross Kedl; Daniel J LaFlamme; Nichole Reisdorph; Katerina J Kechris; Russell P Bowler
Journal:  Am J Respir Cell Mol Biol       Date:  2013-08       Impact factor: 6.914

2.  Enzyme replacement therapy stabilizes obstructive pulmonary Fabry disease associated with respiratory globotriaosylceramide storage.

Authors:  R Y Wang; J T Abe; A H Cohen; W R Wilcox
Journal:  J Inherit Metab Dis       Date:  2008-10-21       Impact factor: 4.982

3.  Natural history of the respiratory involvement in Anderson-Fabry disease.

Authors:  S Magage; J-C Lubanda; Z Susa; J Bultas; D Karetová; R Dobrovolný; M Hrebícek; D P Germain; A Linhart
Journal:  J Inherit Metab Dis       Date:  2007-07-09       Impact factor: 4.982

Review 4.  Fabry disease, respiratory symptoms, and airway limitation - a systematic review.

Authors:  Camilla Kara Svensson; Ulla Feldt-Rasmussen; Vibeke Backer
Journal:  Eur Clin Respir J       Date:  2015-06-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.